Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

At Lahey Hospital & Medical Center, more faulty heart valves are getting fixed without a single chest being cracked open.

On March 12, 2026, the first implant of the ProStyle M(R) Transcatheter Mitral Valve System (ProStyle M(R) ) was successfully completed under pure ultrasound guidance as part of its confirmatory ...

A national study led by investigators from Cedars-Sinai Health Sciences University found that transcatheter tricuspid valve ...

Early feasibility data from two studies of valve replacement presented at TCT 2021 show promise for novel transcatheter devices for mitral and tricuspid regurgitation. The Intrepid (Medtronic) ...

The multibillion-dollar transcatheter heart valves market continues to evolve and grow rapidly. We forecast that total sales ...

Please provide your email address to receive an email when new articles are posted on . Transcatheter tricuspid valve replacement plus medical therapy improved outcomes vs. medical therapy alone in ...

The FDA approved the Evoque tricuspid valve replacement system as the first transcatheter treatment for tricuspid regurgitation (TR), Edwards Lifesciences announced. Evoque gained an indication for ...

At 30 days, bleeding and pacemaker rates were lower than in TRISCEND II, but long-term outcomes are eagerly awaited.

Edwards Lifesciences (NYSE:EW) today unveiled its “Stay in the Race” initiative to support heart valve health.

Advances in the Treatment of Localized Prostate Cancer: The Role of Anatomic and Functional Imaging in Men Managed With Radiotherapy The purpose of this article is to present in a concise manner an ...

KingstronBio takes innovation as its core driving force and has long been deeply engaged in the heart valve field. The ...